Medicine dogs treated with medroxyprogesterone acetate developed important nodules some of which Apo-Medroxy malignant. Mifepristone alters expression example endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. Each mL contains 150 mg of medroxyprogesterone as acetate. Medroxyprogesterone may also increase the risk of uterine or ovarian cancer in some women.
Possible side effects of Apo-Medroxy include:
Apo-Medroxy is used to treat diseases such as: Abnormal Uterine Bleeding, Amenorrhea, Birth Control, Endometrial Cancer, Endometrial Hyperplasia, Prophylaxis, Endometriosis, Gender Dysphoria, Renal Cell Carcinoma.
If the headache returns, or if there is partial but not total relief, the dose may be repeated after 2 hours.